HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 03, March 2019 – Driven by curiosity — Exclusive interview with Nobel laureate Ada Yonath: Her journey in science wasn't always crystal clear       » Your eyes don't deceive you, your brain does       » Organ donations to be computerised in China       » Over One tenth of Chinese people have mental health problems       » AI system can diagnose childhood diseases like doctors       » Bitter rapeseed potential protein source for human nutrition      
INSIDE INDUSTRY
World’s first multiple cancer blood test to be available in India
iGenetic Diagnostics and Lucence Diagnostics partner to deliver cancer blood tests in India

Lucence Diagnostics, a genomic medicine company focused on personalising cancer care, and iGenetic Diagnostics, a pathology company with operations across India, announced a partnership to distribute Lucence’s liquid biopsy tests for early cancer detection and treatment in India.

iGenetic will be distributing Lucence’s flagship liquid biopsy test LiquidHALLMARK,the world’s first blood test to span multiple cancer-causing mutations and viruses.

This test improves cancer diagnosis and treatment selection for patients with advanced cancer. The blood test analyses the cancer-driving mutations from the DNA shed by the tumour into the bloodstream to determine the best available treatment, which include targeted therapy and immunotherapy.

“We are focused on reducing avoidable cancer deaths, particularly in Asia, where more than four million cancer deaths occur annually”, said Dr. Min-Han Tan, founder and CEO of Lucence Diagnostics.

LiquidHALLMARK targets a wide range of cancers, especially cancer types that are most prevalent in Asia, like lung, colon and breast cancers. The turnaround time for this test is also shorter with results coming back in days instead of over a week for current approaches. The test is based on Lucence’s proprietary molecular watermarking technology AmpliMARK with sensitivity and specificity of up to 99.9 percent, which is supported by its AI-powered clinical analytics engine SunTzu.AI.

Click here for the complete issue.

NEWS CRUNCH  
news Which country has the worst sleepers
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy